Copeptin assessment may be useful in acute emergency hospitals with a neurology ward, for patients that present with acute-onset neurological deficits, and may be useful in differentiating between ischemic stroke and hemorrhagic stroke in order to determine the patient’s need for recanalization therapies (the so-called stroke thrombolysis code). The gene discussed is AVP; the disease is hemorrhagic stroke.